Winthrop Advisory Group LLC Takes $1.45 Million Position in HCA Healthcare, Inc. $HCA

Winthrop Advisory Group LLC acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, Holdings Channel reports. The firm acquired 3,797 shares of the company’s stock, valued at approximately $1,454,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in HCA Healthcare by 11.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock valued at $8,796,000 after purchasing an additional 2,698 shares during the last quarter. Park Place Capital Corp grew its stake in shares of HCA Healthcare by 2,336.0% during the 2nd quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock worth $474,000 after purchasing an additional 1,168 shares during the period. Harrell Investment Partners LLC grew its stake in HCA Healthcare by 176.3% in the 2nd quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock valued at $695,000 after acquiring an additional 1,158 shares during the last quarter. Brown Advisory Inc. grew its stake in HCA Healthcare by 53.9% in the 1st quarter. Brown Advisory Inc. now owns 4,630 shares of the company’s stock valued at $1,600,000 after acquiring an additional 1,622 shares during the last quarter. Finally, Farther Finance Advisors LLC boosted its stake in shares of HCA Healthcare by 26.9% during the 1st quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company’s stock worth $395,000 after purchasing an additional 242 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $437.46 on Wednesday. The stock has a 50-day simple moving average of $401.26 and a 200-day simple moving average of $374.10. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $439.01. The firm has a market cap of $102.36 billion, a price-to-earnings ratio of 18.39, a P/E/G ratio of 1.36 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same period in the previous year, the company earned $5.50 EPS. The company’s revenue for the quarter was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio is 12.11%.

Insiders Place Their Bets

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.30% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

HCA has been the topic of several recent analyst reports. Royal Bank Of Canada cut their price objective on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a report on Monday, July 28th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $444.00 price objective on shares of HCA Healthcare in a research report on Tuesday. Wall Street Zen raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th. Bank of America lifted their price objective on shares of HCA Healthcare from $375.00 to $410.00 and gave the stock a “neutral” rating in a report on Wednesday, September 10th. Finally, Morgan Stanley cut their target price on HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating on the stock in a research note on Monday, July 28th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $410.83.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.